학술논문

Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated with AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants
Document Type
Article
Source
In: Journal of Infectious Diseases. (Journal of Infectious Diseases, 15 October 2023, 228(8):1055-1059)
Subject
Language
English
ISSN
15376613
00221899